Headquartered in Cheltenham, England, United Kingdom, T1International is a not-for-profit company operated by diabetes patients and individuals impacted by the disease. The company supports those that are living with type one diabetes by providing resources and tools to local communities to ensure that patients and caregivers have access to diabetes supplies and insulin, regardless of one’s location. T1International provides individuals with a hub of resources and information pertaining to type one diabetes, commonly referred to as T1D, and actively campaigns for sustainable change across the globe to raise awareness of the issues related to this disease.

T1International was founded in 2013 by Elizabeth Rowley. Its team is comprised of medical doctors and researchers that advocate around the world for those that can’t afford or have reasonable access to education, treatment, and supplies. As a not-for-profit, it relies on financial assistance and funding from organizations, donors, and partnerships, however, the company will not accept funding from pharmaceutical industry companies that compromise its mission to campaign for pharmaceutical price gauging and contradict its ability to support sustainable change for patients. T1International is part of a campaign called Missing Medicines, which is a group of European and United Kingdom organizations that promote access to better medicine using advanced research and development procedures in the global public health network.

T1International strives to develop a work diversity that is inclusive for all team members. The company supports flexible work for its staffers with the offering of partial remote jobs, freelance contracts, and part-time schedules.

Headquartered in Cheltenham, England, United Kingdom, T1International is a not-for-profit company operated by diabetes patients and individuals impacted by the disease. The company supports those that are living with type one diabetes by providing resources and tools to local communities to ensure that patients and caregivers have access to diabetes supplies and insulin, regardless of one’s location. T1International provides individuals with a hub of resources and information pertaining to type one diabetes, commonly referred to as T1D, and actively campaigns for sustainable change across the globe to raise awareness of the issues related to this disease.

T1International was founded in 2013 by Elizabeth Rowley. Its team is comprised of medical doctors and researchers that advocate around the world for those that can’t afford or have reasonable access to education, treatment, and supplies. As a not-for-profit, it relies on financial assistance and funding from organizations, donors, and partnerships, however, the company will not accept funding from pharmaceutical industry companies that compromise its mission to campaign for pharmaceutical price gauging and contradict its ability to support sustainable change for patients. T1International is part of a campaign called Missing Medicines, which is a group of European and United Kingdom organizations that promote access to better medicine using advanced research and development procedures in the global public health network.

T1International strives to develop a work diversity that is inclusive for all team members. The company supports flexible work for its staffers with the offering of partial remote jobs, freelance contracts, and part-time schedules.